RET kinase inhibitors
Disclosed herein are compounds of formula I:or a pharmaceutically acceptable salt thereof, where the variables are as defined herein. These compounds are useful in treating RET associated cancers. Formulations containing the compounds of formula I and methods of making the compounds of formula I are...
Saved in:
Main Authors | , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
30.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!